Transcriptional Profiling of the Circulating Immune Response to Lassa Virus in an Aerosol Model of Exposure

Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
PLoS Neglected Tropical Diseases (Impact Factor: 4.45). 04/2013; 7(4):e2171. DOI: 10.1371/journal.pntd.0002171
Source: PubMed


Lassa virus (LASV) is a significant human pathogen that is endemic to several countries in West Africa. Infection with LASV leads to the development of hemorrhagic fever in a significant number of cases, and it is estimated that thousands die each year from the disease. Little is known about the complex immune mechanisms governing the response to LASV or the genetic determinants of susceptibility and resistance to infection. In the study presented here, we have used a whole-genome, microarray-based approach to determine the temporal host response in the peripheral blood mononuclear cells (PBMCs) of non-human primates (NHP) following aerosol exposure to LASV. Sequential sampling over the entire disease course showed that there are strong transcriptional changes of the immune response to LASV exposure, including the early induction of interferon-responsive genes and Toll-like receptor signaling pathways. However, this increase in early innate responses was coupled with a lack of pro-inflammatory cytokine response in LASV exposed NHPs. There was a distinct lack of cytokines such as IL1β and IL23α, while immunosuppressive cytokines such as IL27 and IL6 were upregulated. Comparison of IRF/STAT1-stimulated gene expression with the viral load in LASV exposed NHPs suggests that mRNA expression significantly precedes viremia, and thus might be used for early diagnostics of the disease. Our results provide a transcriptomic survey of the circulating immune response to hemorrhagic LASV exposure and provide a foundation for biomarker identification to allow clinical diagnosis of LASV infection through analysis of the host response.

Download full-text


Available from: John H Connor, Oct 05, 2015
27 Reads
  • Source
    • "Kash et al. (2006) have also demonstrated that EBOV infection of human hepatocytes resulted in the suppression of antiviral responses, and Yen et al., (2011)identified discernable differences in the immune responses of nonhuman primates (NHPs) treated with coagulation inhibitors as compared to untreated animals in a lethal EBOV infection model. Connor and colleagues have also demonstrated through transcriptional profiling that Lassa virus infection resulted in the early induction of interferon-responsive and Toll-like receptor-mediated signaling networks in aerosol-exposed NHPs (Malhotra et al., 2013). Further, analyses of host gene expression during MPXV infection by Alkhalil et al. (2010) and Rubins et al. (2011) demonstrated that infection resulted in the global suppression of host gene expression. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Currently, there is a paucity of information regarding the molecular pathogenesis for many high-consequence pathogens (HCPs) that pose direct threats to public health and security both nationally and internationally. For example, variola virus (VARV), the etiologic agent of smallpox, was responsible for ~500 million human fatalities in the 20(th) century prior to its successful eradication in May 1980 [1]. Following the cessation of routine vaccinia virus (VACV) vaccination, a significant portion of the global population has been left vulnerable to VARV. This has resulted in significant concerns regarding the potential release of VARV, or another closely related orthopoxvirus, such as monkeypox virus (MPXV), to an increasingly vulnerable population. This article is protected by copyright. All rights reserved.
    Pathogens and Disease 03/2014; 71(2). DOI:10.1111/2049-632X.12163 · 2.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Lassa virus (LASV) is the causative agent of Lassa Fever and is responsible for several hundred thousand infections and thousands of deaths annually in West Africa. LASV and the non-pathogenic Mopeia virus (MOPV) are both rodent-borne African arenaviruses. A live attenuated reassortant of MOPV and LASV, designated ML29, protects rodents and primates from LASV challenge and appears to be more attenuated than MOPV. To gain better insight into LASV-induced pathology and mechanism of attenuation we performed gene expression profiling in human peripheral blood mononuclear cells (PBMC) exposed to LASV and the vaccine candidate ML29. PBMC from healthy human subjects were exposed to either LASV or ML29. Although most PBMC are non-permissive for virus replication, they remain susceptible to signal transduction by virus particles. Total RNA was extracted and global gene expression was evaluated during the first 24 hours using high-density microarrays. Results were validated using RT-PCR, flow cytometry and ELISA. LASV and ML29 elicited differential expression of interferon-stimulated genes (ISG), as well as genes involved in apoptosis, NF-kB signaling and the coagulation pathways. These genes could eventually serve as biomarkers to predict disease outcomes. The remarkable differential expression of thrombomodulin, a key regulator of inflammation and coagulation, suggests its involvement with vascular abnormalities and mortality in Lassa fever disease.
    PLoS Neglected Tropical Diseases 09/2013; 7(9):e2406. DOI:10.1371/journal.pntd.0002406 · 4.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The pathogenesis of Lassa fever (LF), a hemorrhagic fever endemic to West Africa, remains unclear. We previously compared Lassa virus (LASV) with its genetically close, but nonpathogenic homolog Mopeia virus (MOPV) and demonstrated that the strong activation of antigen-presenting cells (APC), including type I IFN production, observed in response to MOPV probably plays a crucial role in controlling infection. We show here that human macrophages (MP) produce large amounts of CC and CXC chemokines in response to MOPV infection, whereas dendritic cells (DC) release only moderate amounts of CXC chemokines. However, in the presence of autologous T cells, DCs produced CC and CXC chemokines. Chemokines were produced in response to type I IFN synthesis, as the levels of both mediators were strongly correlated and the neutralization of type I IFN resulted in an inhibition of chemokine production. By contrast, LASV induced only low levels of CXCL-10 and CXCL-11 production. These differences in chemokine production may profoundly affect the generation of virus-specific T-cell responses and may therefore contribute to the difference of pathogenicity between these two viruses. In addition, a recombinant LASV (rLASV) harboring the NP-D389A/G392A mutations, which abolish the inhibition of type I IFN response by nucleoprotein (NP), induced the massive synthesis of CC and CXC chemokines in both DC and MP, confirming the crucial role of arenavirus NP in immunosuppression and pathogenicity. Finally, we confirmed, using PBMC samples and lymph nodes obtained from LASV-infected cynomolgus monkeys, that LF was associated with high levels of CXC chemokine mRNA synthesis, suggesting that the very early synthesis of these mediators may be correlated with a favourable outcome.
    PLoS Neglected Tropical Diseases 01/2014; 8(1):e2637. DOI:10.1371/journal.pntd.0002637 · 4.45 Impact Factor
Show more